These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 11949846)

  • 1. The role of palliative radiotherapy in locally advanced non-small cell lung cancer.
    Cetingoz R; Kentli S; Uruk O; Demirtas E; Sen M; Kinay M
    Neoplasma; 2001; 48(6):506-10. PubMed ID: 11949846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
    Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
    J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of curative and palliative radiotherapy efficacy in unresectable advanced non-small cell lung cancer patients with or without metastasis.
    Unlu I; Diniz G; Komurcuoglu B; Gayaf M; Gokce T; Karadogan I; Akcay C
    Saudi Med J; 2006 Jun; 27(6):849-53. PubMed ID: 16758049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
    van den Hout WB; Kramer GW; Noordijk EM; Leer JW
    J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of palliative hypofractionated radiotherapy (8.5 Gy x 2) for patients with symptomatic non-small-cell lung cancer.
    Cross CK; Berman S; Buswell L; Johnson B; Baldini EH
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1098-105. PubMed ID: 15001250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is re-irradiation effective in symptomatic local recurrence of non small cell lung cancer patients? A single institution experience and review of the literature.
    Cetingoz R; Arican-Alicikus Z; Nur-Demiral A; Durmak-Isman B; Bakis-Altas B; Kinay M
    J BUON; 2009; 14(1):33-40. PubMed ID: 19373944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.
    Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y
    Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
    Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD
    Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endobronchial brachytherapy for symptom palliation in non-small cell lung cancer--analysis of symptom response, endoscopic improvement and quality of life.
    Mallick I; Sharma SC; Behera D
    Lung Cancer; 2007 Mar; 55(3):313-8. PubMed ID: 17157949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative radiotherapy in asymptomatic patients with locally advanced, unresectable, non-small cell lung cancer.
    Reinfuss M; Skołyszewski J; Kowalska T; Rzepecki W; Kociołek D
    Strahlenther Onkol; 1993 Dec; 169(12):709-15. PubMed ID: 7506846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inoperable non-small cell lung cancer: palliative radiotherapy with two weekly fractions.
    Vyas RK; Suryanarayana U; Dixit S; Singhal S; Bhavsar DC; Neema JP; Baboo HA
    Indian J Chest Dis Allied Sci; 1998; 40(3):171-4. PubMed ID: 9919836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Single-dose palliative radiotherapy in inoperable non-small-cell lung carcinoma].
    Scolaro T; Bacigalupo A; Giudici S; Guenzi M; Vitale V
    Radiol Med; 1995 Dec; 90(6):808-11. PubMed ID: 8685468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience.
    Machtay M; Hsu C; Komaki R; Sause WT; Swann RS; Langer CJ; Byhardt RW; Curran WJ
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):667-71. PubMed ID: 15927409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer.
    Choy H; Nabid A; Stea B; Scott C; Roa W; Kleinberg L; Ayoub J; Smith C; Souhami L; Hamburg S; Spanos W; Kreisman H; Boyd AP; Cagnoni PJ; Curran WJ
    J Clin Oncol; 2005 Sep; 23(25):5918-28. PubMed ID: 16135463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer.
    Zimmermann FB; Geinitz H; Schill S; Grosu A; Schratzenstaller U; Molls M; Jeremic B
    Lung Cancer; 2005 Apr; 48(1):107-14. PubMed ID: 15777977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of the Dutch National study of the palliative effect of irradiation using two different treatment schemes for non-small-cell lung cancer.
    Kramer GW; Wanders SL; Noordijk EM; Vonk EJ; van Houwelingen HC; van den Hout WB; Geskus RB; Scholten M; Leer JW
    J Clin Oncol; 2005 May; 23(13):2962-70. PubMed ID: 15860852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study.
    Kong FM; Ten Haken RK; Schipper MJ; Sullivan MA; Chen M; Lopez C; Kalemkerian GP; Hayman JA
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):324-33. PubMed ID: 16168827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Wu KL; Zang Z; Zhao S
    Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.